Memantine in Patients With Chronic Glaucoma
1 other identifier
interventional
1,119
0 countries
N/A
Brief Summary
Randomized double-masked clinical trial of memantine in patients with glaucoma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Mar 1999
Longer than P75 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1999
CompletedFirst Submitted
Initial submission to the registry
August 31, 2005
CompletedFirst Posted
Study publicly available on registry
September 2, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedNovember 4, 2010
November 1, 2010
6.8 years
August 31, 2005
November 3, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Progression of glaucoma
Interventions
Eligibility Criteria
You may qualify if:
- Glaucoma damage on examination of visual field and optic disc
- Good visual acuity (with glasses if needed)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allerganlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 31, 2005
First Posted
September 2, 2005
Study Start
March 1, 1999
Primary Completion
January 1, 2006
Study Completion
August 1, 2006
Last Updated
November 4, 2010
Record last verified: 2010-11